Successful mycophenolate mofetil treatment of glomerular disease

American Journal of Kidney Diseases

Volumn 31, Issue 2, 1998, Pages

  Briggs, William A ^a   Choi, Michael J ^a   Scheel Jr , Paul J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glomerular disease; Mycophenolate mofetil; Nephrotic syndrome

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG RESISTANCE; FEMALE; FOCAL GLOMERULONEPHRITIS; GLOMERULOPATHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; RELAPSE; STEROID THERAPY; TREATMENT OUTCOME;

EID: 17344373954     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9469489     Document Type: Article

References (10)

1. Deierhoi MH, Kauffman RS, Hudson SL, Barber WH, Curtis JJ, Julian BA, Gaston RS, Laskow DA, Diethelm AG: Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center. Ann Surg 217:476-484, 1993
2. Sollinger HW, for the U.S. Renal Transplant Mycophenolate Mofetil Study Group: Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60:225-232, 1995
3. European Mycophenolate Mofetil Cooperative Study Group: Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and glucocorticoids for prevention of acute rejection. Lancet 345:1321-1325, 1995
4. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group: A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61:1029-1037, 1996
5. Morris RE, Hoyt EG, Murphy MP: Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc 22:1659-1662, 1990
6. Eugui EM, Almquist S, Muller CD, Allison AC: Lymphocyte selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion. Scand J Immunol 33:161-173, 1991
7. Allison AC, Eugui EM, Sollinger HW: Mycophenolate mofetil (RS-61443): Mechanism of action and effects in transplantation. Transplant Rev 7:129-139, 1993
8. Allison AC: Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation. Transplant Proc 26:3205-3210, 1994
9. Allison AC, Kowalski WJ, Muller CJ, Waters RV, Eugui EM: Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules. Transplant Proc 25:67-70, 1993 (suppl 2)
10. Corna D, Morigi M, Facchinetti D, Bertani T, Zoja C, Remuzzi G: Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease. Kidney Int 51:1583-1589, 1997